IMUNON's Ovarian Cancer R&D Day to Feature Presentations From IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management

GlobeNewswireSep 9 08:30 ET

Imunon Files for Stock Resale by Security Holders

MT NewswiresAug 29 10:29 ET

IMUNON to Host R&D Day on September 18th

Yahoo FinanceAug 28 08:30 ET

Express News | HC Wainwright & Co. Reiterates Buy on Imunon, Maintains $14 Price Target

BenzingaAug 15 07:25 ET

Imunon Analyst Ratings

BenzingaAug 15 07:22 ET · Ratings

Earnings Call: Imunon Reports Q2 Financials, Advances in Cancer Trials

InvestingAug 14 20:58 ET